PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
D-003 (a mixture of high aliphatic primary acids from sugarcane wax) significantly lowers serum total cholesterol (TC) and LDL-C while increasing HDL-C in animal and human studies [PMID:27751878].
Methanol fractions of S. officinarum juice and the isolated flavone tricin-7-O-(2''-α-L-rhamnopyranosyl)-α-D-galacturonide significantly inhibited nociceptive responses in mice models [PMID:32515612].
S. officinarum juice significantly decreased levels of serum ALT, AST, ALP, and total bilirubin in mice with isoniazid-induced oxidative liver injury [PMID:26411113].
A patented polyphenol-rich sugar cane extract (PRSE) demonstrated efficient antimicrobial activity against common human pathogens [PMID:33500371].
Safety & adverse effects
Evidence summary
PubMed sources
- 1.PMID: 35847309 (2022) — Impact of Agroclimatic Variables on Proteogenomics in Sugar Cane (Saccharum spp.) Plant Productivity. · ACS omega
- 2.PMID: 38874798 (2024) — A study on waterlogging tolerance in sugarcane: a comprehensive review. · Molecular biology reports
- 3.PMID: 39741856 (2024) — Sugar Cane (Saccharum officinarum L.) Waste Synthesized Si,N,S-Carbon Quantum Dots as High-Performance Corrosion Inhibitors for Mild Steel in Hydrochloric Acid. · ACS omega
- 4.PMID: 40463462 (2025) — Sugar cane extracts as natural taste modulators: potential for sugar reduction in beverages and beyond. · Frontiers in nutrition
- 5.PMID: 27751878 (2016) — D-003 (Saccharum officinarum): The forgotten lipid-lowering agent.